newsfilter
← Latest News
GlobeNewswire·

Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum

EQ

LA JOLLA, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that